{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:25:22Z","timestamp":1774362322911,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijbiomac.2022.02.006","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T16:18:02Z","timestamp":1644337082000},"page":"373-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system"],"prefix":"10.1016","volume":"204","author":[{"given":"Aakriti","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Yadagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manorma","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag Kumar","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Om Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam Lal","family":"Mudavath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12982-017-0065-3","article-title":"Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings emerging themes in epidemiology","volume":"14","author":"Debroy","year":"2017","journal-title":"Emerg. Themes Epidemiol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1473-3099(08)70159-2","article-title":"Cutaneous leishmaniasis","volume":"8","author":"Khatami","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0020","article-title":"Nano- and microformulations to advance therapies for visceral leishmaniasis","author":"Varma","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0163-4453(99)90000-2","article-title":"Visceral leishmaniasis: biology of the parasite","volume":"39","author":"Hommel","year":"1999","journal-title":"J. Infect."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0030","article-title":"Leishmaniasis: a review","volume":"6","author":"Arenas","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0040","series-title":"Tropical Medicine and Infectious Disease Neglected Tropical Diseases: Epidemiology and Global Burden","author":"Mitra","year":"2017"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/jtim-2015-0002","article-title":"Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment","volume":"3","author":"Georgiadou","year":"2016","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0050","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Molecules pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"Serrano","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0060","series-title":"Oral Amphotericin B: The Journey From Bench to Market","author":"Serrano","year":"2017"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0070","author":"Singh"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0075","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/156.6.885","article-title":"Pentamidine pharmacokinetics in patients with AIDS with impaired renal function","volume":"156","author":"Conte","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0085","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.00014-08","article-title":"Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients","volume":"52","author":"Dorlo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0090","series-title":"Miltefosine in the Treatment of Leishmaniasis: Clinical Evidence for Informed Clinical Risk Management","author":"Sundar","year":"2007"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/08982104.2012.762519","article-title":"Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis","volume":"23","author":"Momeni","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0100","series-title":"Pharmaceutics Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy","author":"Faustino","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal Amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/21691401.2014.953633","article-title":"Application of liposomes in medicine and drug delivery","volume":"44","author":"Daraee","year":"2016","journal-title":"Artif. Cells Nanomedicine Biotechnol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1021\/acs.langmuir.6b04304","article-title":"Fusogenic liposomes as nanocarriers for the delivery of intracellular proteins","volume":"33","author":"Kube","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0125","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1021\/acs.analchem.7b01397","article-title":"Liposome-coated persistent luminescence nanoparticles as luminescence trackable drug carrier for chemotherapy","volume":"89","author":"Chen","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0130","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.2147\/IJN.S55807","article-title":"Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy","volume":"11","author":"Wang","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0135","series-title":"Liposome: Classification, Preparation, and Applications","author":"Akbarzadeh","year":"2013"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0140","series-title":"Pharmaceutics Liposomal Formulations in Clinical Use: An Updated Review","author":"Bulbake","year":"2017"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/pj.2014.40","article-title":"Surface engineering of nanoparticles for therapeutic applications","volume":"46","author":"Kobayashi","year":"2014","journal-title":"Polym. J."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116408","article-title":"Carboxymethyl chitosan has sensitive two-way CO2-responsive hydrophilic\/hydrophobic feature","volume":"241","author":"Shieh","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.carbpol.2005.08.006","article-title":"Effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates","volume":"63","author":"Aiping","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.carbon.2012.08.020","article-title":"Carboxymethyl chitosan-functionalized graphene for label-free electrochemical cytosensing","volume":"51","author":"Yang","year":"2013","journal-title":"Carbon N. Y."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.colsurfb.2017.02.025","article-title":"The pH sensitive properties of carboxymethyl chitosan nanoparticles cross-linked with calcium ions","volume":"153","author":"Kalliola","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111279","article-title":"Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate","volume":"117","author":"Singh","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0175","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acs.molpharmaceut.0c00313","article-title":"Enhancing safety and efficacy by altering the toxic aggregated state of amphotericin B in lipidic nanoformulations","volume":"17","author":"Das","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040235","article-title":"Preparation and characterization of spherical amorphous solid dispersion with amphotericin B","volume":"10","author":"Mehenni","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0185","series-title":"A Facile Microfluidic Method for Production of Amphotericin B Lipid Complex","author":"Yen","year":"2017"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0190","article-title":"Biomimetic remineralization of demineralized dentine using scaffold of CMC\/ACP nanocomplexes in an in vitro tooth model of deep caries","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0195","series-title":"Carboxymethyl-chitosan as Consolidation Agent for Old Documents on Paper Support","author":"Ardelean","year":"2009"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00396-015-3804-4","article-title":"Synthesis and characterization of poly (N-isopropylacrylamide)-g-carboxymethyl chitosan copolymer-based doxorubicin-loaded polymeric nanoparticles for thermoresponsive drug release","volume":"294","author":"Antoniraj","year":"2016","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijbiomac.2018.03.133","article-title":"Amino acid-grafted and N-acylated chitosan thiomers: construction of 3D bio-scaffolds for potential cartilage repair applications","volume":"114","author":"Medeiros Borsagli","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9010007","article-title":"Investigation of drug-polymer compatibility using chemometric-assisted UV-spectrophotometry","volume":"9","author":"Mohamed","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.13005\/ojc\/320150","article-title":"Adsorptive removal of lead and cadmium ions using cross-linked CMC Schiff base: isotherm, kinetics and catalytic activity","volume":"32","author":"Moganavally","year":"2016","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jps.2600670334","article-title":"Ambiguities in IR and X-ray characterization of amphotericin B","volume":"67","author":"Schwartzman","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0225","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.xphs.2019.04.006","article-title":"Effect of amorphous nanoparticle size on bioavailability of anacetrapib in dogs","volume":"108","author":"Kesisoglou","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0230","series-title":"Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis","author":"Saravolatz","year":"2006"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6631.1000171","article-title":"Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets","volume":"06","author":"Baishya","year":"2017","journal-title":"J. Dev. Drugs"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/cancers12030593","article-title":"Studies on the drug loading and release profiles of degradable chitosan-based multilayer films for anticancer treatment","volume":"12","author":"Sun","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0250","series-title":"Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-assembled Nanoparticles for Oral Delivery of Insulin","author":"Shan","year":"2015"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0255","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ijbiomac.2018.09.185","article-title":"Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios","volume":"120","author":"Hejjaji","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(91)90287-X","article-title":"An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop","volume":"70","author":"Lehr","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0265","series-title":"Developments of Mucus Penetrating Nanoparticles","author":"Liu","year":"2015"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0270","series-title":"A Novel Method for Preparing Surface-modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations","author":"Salama","year":"2015"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0275","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0285","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0144-8617(03)00051-1","article-title":"Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions","volume":"53","author":"Chen","year":"2003","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0295","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbm.a.30917","article-title":"In vitro evaluation of in situ gels as short term vitreous substitutes","volume":"79","author":"Suri","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110297","article-title":"Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection","volume":"128","author":"Kaur","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0305","doi-asserted-by":"crossref","first-page":"27502","DOI":"10.1039\/D0RA04266H","article-title":"Sensible graphene oxide differentiates macrophages and: leishmania: a bio-nano interplay in attenuating intracellular parasite","volume":"10","author":"Singh","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0141-8130(86)90014-0","article-title":"Glutamate glucan and aminogluconate glucan, new chelating polyampholytes obtained from chitosan","volume":"8","author":"Muzzarelli","year":"1986","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cano-Cebrian","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0320","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10856-008-3659-z","article-title":"Trimethyl chitosan and its applications in drug delivery","volume":"20","author":"Mourya","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.03.044","article-title":"Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1\u03b2-induced apoptosis","volume":"541","author":"Chen","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0335","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/acsami.6b00821","article-title":"Transport mechanisms of solid lipid nanoparticles across Caco-2 cell monolayers and their related cytotoxicology","volume":"8","author":"Chai","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0340","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1021\/mp500439c","article-title":"Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge","volume":"11","author":"Bannunah","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0345","first-page":"327","article-title":"Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection","volume":"9","author":"Yang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0355","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1021\/acsabm.8b00830","article-title":"PH-triggered charge-reversal mesoporous silica nanoparticles stabilized by chitosan oligosaccharide\/carboxymethyl chitosan hybrids for effective intracellular delivery of doxorubicin","volume":"2","author":"Cui","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2022.02.006_bb0360","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10965-009-9333-4","article-title":"Preparation and swelling kinetics of pH-sensitive photocrosslinked hydrogel based on carboxymethyl chitosan","volume":"17","author":"Yin","year":"2010","journal-title":"J. Polym. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022002379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022002379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:25:03Z","timestamp":1758878703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022002379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":70,"alternative-id":["S0141813022002379"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.006","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}